Financial News
Latest News about MRK
Recent news which mentions MRK
From Motley Fool
From Motley Fool
Despite Game-Changing Treatment News, It’s Not Over for Novavax Yet
October 04, 2021
From InvestorPlace
Moderna Shares Linger At 2-Month Lows: What's Next For The COVID-19 Vaccine Company
October 04, 2021
From Benzinga
Why This Investor Keeps Buying Moderna Shares As The Stock Falls
October 04, 2021
From Benzinga
Why Moderna Stock Is Sliding Again Today
October 04, 2021
From Motley Fool
U.S. COVID-19 cases and hospitalizations continue to decline, but experts lament preventable deaths that have pushed toll above 700,000
October 04, 2021
From MarketWatch
Tesla and Merck Give Investors Some Hope
October 04, 2021
From Benzinga
A Glimpse of This Week's Earnings Calendar
October 04, 2021
From Benzinga
2 Best Biotech Stocks to Buy In October
October 04, 2021
From Motley Fool
Why BioNTech Shares Are Trading Lower Again Today
October 04, 2021
From Benzinga
Why Moderna Shares Continue To Fall Today
October 04, 2021
From Benzinga
From MarketWatch
3 Stocks That Might Soar With Pills for COVID
October 03, 2021
From Motley Fool
The Week Ahead In Biotech (Oct. 3-9): ChemoCentryx FDA Decision, Conference Presentations, IPOs And More
October 03, 2021
From Benzinga
Here Are the Leaders in the Race to Develop a COVID-19 Pill
October 03, 2021
From Motley Fool
2 Leading Healthcare Stocks to Buy in 2021 and Beyond
October 02, 2021
From Motley Fool
2 Ridiculously Cheap Growth Stocks to Buy
October 02, 2021
From Motley Fool
Exactly How I'd Invest $5,000 if I Had to Start From Scratch Today
October 02, 2021
From Motley Fool
What Merck’s antiviral pill could mean for vaccine hesitancy — ‘It’s not a magic pill’
October 01, 2021
From MarketWatch
4 Top Stock Trades for Monday: BTC, ETH, NVAX, MRNA
October 01, 2021
From InvestorPlace
Why Moderna Stock Plunged Today
October 01, 2021
From Motley Fool
PreMarket Prep: Putting A Bow On The S&P 500 In Q3
October 01, 2021
From Benzinga
Merck Shouldn't Matter to the Nasdaq's Vaccine Stocks
October 01, 2021
From Motley Fool
From Benzinga
Activist Investor Thinks Merck Undervalues Acceleron Buy
October 01, 2021
From Benzinga
From MarketWatch
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
